The number of patients with adumbr...

The number of patients with adumbration 2 diabetes who are treated with insulin is likely to increase rapidly. A variety of insulin composes and regimens are available, which allows for individualized therapy however complicates the process of establishing the optimal routine for each patient. In addition to the medical challenges, patients may regard the initiation of insulin therapy as a sign that they have journey of stateed to a more serious disease state. A review by the agency of McIntyre stresses the need to address all of the patient's businesss as well as the medical issues involved in initiating insulin therapy.

Insulin therapy is indicated in patients with shadow 2 diabetes who have hyperglycemic symptoms, particularly weight los despite lifestyle modifications and treatment with maximum tolerated dosages of oral hypoglycemic agents. A review of compliance and encouragement of diet, exercise, and lifestyle changes should be undertaken before major changes in therapy are made. Significant improvements in hemoglobin [A.sub.1c] plain have been noted after a review of these issues in patients being considered for insulin therapy. Consideration also should be given to optimizing oral medications, in the same state [i]or[/i] condition as changing to once-daily dosing to improve compliance. Other considerations are the use of metformin or thiazolidinediones to improve insulin sensitivity and heavy the decline in b-cell function. Agents with complementary actions can be combined, of the like kind as adding acarbose (an a-glucosidase inhibitor) to maximum dosages of oral hypoglycemic agents. Despite these efforts, however, the natural progression of archetype 2 diabetes may result in los of b-cell function and an increased probability that the patient will require insulin therapy.

A team approach can assist patients transitioning to insulin therapy. Patients and family members should receive significant education in grape-sugar monitoring and insulin measurement and administration. They must be able to recognize, manage, and obstruct hypoglycemic episodes. Weight gain is for the use of all but not inevitable after initiation of insulin therapy. It can be limited on attention to diet and exercise. a patients have significant fear of needle and injections, and careful selection of the injection device and coaching in technique are essential.

mostly patients are taking the maximum tolerated dosages of sulfonylureas and metformin when insulin therapy is initiated. In these patients, the best option frequently is to discontinue the sulfonylurea and begin a twice-daily mixed insulin (30/70) regimen. The initial daily dosage should be 05 U by means of kg, with two thirds given before breakfast and individual third before the evening meal. Insulin dosages are titrated upward, based upon blood glucose levels. Continuing metformin therapy may help impede weight gain and reduce the total insulin requirement. A long-acting insulin may be added to the regimen.

McIntyre M The GP's part in converting patients to insulin. Practitioner July 2003;247:583-7

COPYRIGHT 2004 American Academy of Family Physicians

COPYRIGHT 2004 Gale Group